Fujino Rika, Masuoka Yoshihito, Mashiko Taro, Nakano Akira, Hirabayashi Kenichi, Nakagohri Toshio
Department of Surgery, Tokai University School of Medicine, Shimokasuya 143, Isehara, Kanagawa, 2591193, Japan.
Department of Pathology, Tokai University School of Medicine, Shimokasuya 143, Isehara, Kanagawa, 2591193, Japan.
World J Surg Oncol. 2020 Oct 23;18(1):271. doi: 10.1186/s12957-020-02054-9.
Intraductal papillary neoplasm of the bile duct (IPNB) is considered a pre-cancerous biliary lesion and/or an early cancer lesion, although its classification remains unclear. The 2019 revised edition of the World Health Organization Classification of Tumors of the Digestive System proposed type 1 and type 2 as new classification categories, and meta-analyses and/or multi-center cohort studies are beginning to be reported. However, treatment for IPNB recurrence and metastasis remains unclear.
A 60-year-old man who was referred to our hospital after a suspected liver tumor was diagnosed using abdominal ultrasonography. Imaging findings revealed an irregularly shaped tumor in segment 5 (S5) of the liver (size 20 mm). The S5 lesion was suspected as IPNB, and segmentectomy was performed. The pathological findings revealed invasive carcinoma derived from IPNB, and immunohistochemistry revealed positive expression of MUC1, MUC5AC, and MUC6, but negative expression of CDX2 and MUC2. At 9 months after the surgery, computed tomography revealed a tumor in the right bile duct, which was diagnosed as liver recurrence of IPNB, and right hepatectomy was performed. The histopathological findings were the same as for the first resected specimen (i.e., IPNB). At 45 months after the second surgery, computed tomography revealed nodules in both lungs, which were diagnosed as lung metastases from IPNB and resected in two separate procedures. The pathological findings were metastatic carcinoma from IPNB for both lung lesions. The patient is currently alive and undergoing adjuvant chemotherapy (S-1), which was initiated 64 months after the first resection and 12 months after resection of the lung metastases.
We encountered a rare case of lung metastases from IPNB, which were diagnosed immunohistologically. Because IPNB is generally a slow-growing tumor, resection may be feasible for IPNB recurrence and/or metastasis, which may be detected during long-term follow-up. Thus, even if resection is performed for primary IPNB, additional surgical treatment may be feasible in this setting.
胆管内乳头状肿瘤(IPNB)被认为是一种癌前胆道病变和/或早期癌症病变,尽管其分类仍不明确。2019年修订版的世界卫生组织消化系统肿瘤分类提出了1型和2型作为新的分类类别,并且开始有荟萃分析和/或多中心队列研究的报道。然而,IPNB复发和转移的治疗仍不明确。
一名60岁男性因腹部超声检查怀疑肝脏肿瘤而被转诊至我院。影像学检查发现肝脏第5段(S5)有一个形状不规则的肿瘤(大小为20毫米)。S5病变疑似为IPNB,遂行肝段切除术。病理检查结果显示为源自IPNB的浸润性癌,免疫组化显示MUC1、MUC5AC和MUC6呈阳性表达,但CDX2和MUC2呈阴性表达。术后9个月,计算机断层扫描显示右胆管有肿瘤,诊断为IPNB肝复发,遂行右半肝切除术。组织病理学检查结果与首次切除标本相同(即IPNB)。第二次手术后45个月,计算机断层扫描显示双肺有结节,诊断为IPNB肺转移,并分两次手术切除。两个肺病变的病理检查结果均为IPNB转移癌。患者目前尚存活,正在接受辅助化疗(S-1),该化疗在首次切除后64个月和肺转移灶切除后12个月开始。
我们遇到了一例罕见的IPNB肺转移病例,通过免疫组化确诊。由于IPNB通常是一种生长缓慢的肿瘤,对于IPNB复发和/或转移,在长期随访中可能检测到,手术切除可能是可行的。因此,即使对原发性IPNB进行了切除,在这种情况下额外的手术治疗可能也是可行的。